Rajendar K Mittapalli

Rajendar K Mittapalli

Pfizer Inc. - New York / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4389691
-
person_outline Rajendar K Mittapalli's MOST POPULAR ARTICLES
1-) Heterogeneous blood–tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancerPR Lockman, RK Mittapalli, KS Taskar, V Rudraraju, B Gril, KA Bohn, ...Clinical Cancer Research 16 (23), 5664-5678, 20106082010
2-) Orodispersible tablets: An overviewS Bandari, RK Mittapalli, R GannuAsian Journal of Pharmaceutics (AJP) 2 (1), 20085162008
3-) Strategies to improve delivery of anticancer drugs across the blood–brain barrier to treat glioblastomaRK Oberoi, KE Parrish, TT Sio, RK Mittapalli, WF Elmquist, JN SarkariaNeuro-oncology 18 (1), 27-36, 20152642015
4-) Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancerFC Thomas, K Taskar, V Rudraraju, S Goda, HR Thorsheim, JA Gaasch, ...Pharmaceutical research 26 (11), 2486-2494, 20092712009
5-) Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast CancerKS Taskar, V Rudraraju, RK Mittapalli, R Samala, HR Thorsheim, ...Pharmaceutical Research, 1-12, 20122302012